<DOC>
	<DOCNO>NCT00367146</DOCNO>
	<brief_summary>The use CNIs ( CSA FK ) primary immunosuppressive drug pediatric liver transplantation one main cause chronic kidney disease patient long term . The study objective evaluation safety modification immunosuppression dual-immunosuppression ( CSA FK plus steroid ) triple immunosuppression ( MMF plus CSA ( reduce dosage ) plus steroid .</brief_summary>
	<brief_title>MMF After Pediatric Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>patient pediatric liver transplantation acute rejection last half year concomitant malign disease ( e.g . ptld ) neutropenia ( granulocytes &lt; 1000/Âµl ) systemic infection thrombopenia ( &lt; 80/nl )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>liver transplantation</keyword>
	<keyword>child</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>mycophenolatmofetil</keyword>
	<keyword>calcineurin inhibitor</keyword>
	<keyword>kidney disease</keyword>
</DOC>